| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > 10 Tips for Better Participation in Meetings |
|
Digg It - 10 Tips for Better Participation in Meetings
A meeting can be led (or misled) from any chair in the room. Here's how to make sure that you add val According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product ue to your next meeting. 1) Focus on the issue. Avoid stories, jokes, and unrelated issues. These wa ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in te time, distract focus, and mislead others. Save the fun for social occasions where it will be appre lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ciated. 2) Take a moment to organize your thoughts before speaking. Then express your idea simply, l here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe gically, and concisely. People are more receptive to ideas that they understand. Long, complex explan d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ations always work against you. 3) Use positive comments in the meeting. Negative comments create de ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ensive reactions that distract from your goals. 4) If it is your meeting, ask a facilitator to lead easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi the group through major solution finding activities. This frees you to participate in them and gives nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically esponsibility for keeping order to an impartial party. 5) Test your comments by asking, "How does th and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ is add value to our work?" If you sense it subtracts, keep silent or jot down the idea. This frees yo ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi r to think about what others are saying, and that idea may be more appropriate later. 6) Use structu ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ed activities. These process tools ensure equitable participation and systematic progress toward resu dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod lts. 7) Respect others. Different views force us to think. After all, if we were all the same, they cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ould need only one of us. 8) If you notice that you are speaking more than anyone else in a meeting, tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen take a rest. You are either dominating the meeting with monologues or conducting a conversation with t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel a minority of the participants. In either case, you're preventing the participants from working toget ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust her as a team. 9) When voting give the participants veto power over ideas they strongly oppose. This y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products avoids sabotage or partial support from people who were forced to accept decisions that harm them. 1 . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de 0) Rescue wayward meetings by challenging seemingly unrelated comments. Ask, "How does that contribut elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip to the issue?" Note: Learn more about Effective Meetings at: http://www.squidoo.com/OneGreatMeeting tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:4 Methods That Will Help You Quit Your Day Job With $1000 Days! Who Gets Funded Today? Are You That Great Entrepreneur?
|